Breast cancer subtypes are categorized by molecular markers such as the human epidermal growth factor receptor 2 (HER2), progesterone receptor (PR), and estrogen receptor (ER), and each subtype has a unique behavior and response to chemotherapy [16, 17]. The gene discussed is ERBB2; the disease is breast carcinoma.